CFDE Data Portal | Search EGOT

	Label	Description
	EGOT associations Collection (Entity type)	Associations for EGOT_associations
	EGOT associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	EGOT Gene (Entity type)	ENSG00000235947 - eosinophil granule ontogeny transcript
	GSE143782 calcitriol 7 v 11 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE171692 FXN knockdown 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE143782 calcitriol 3 v 11 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE239844 crizotinib 8 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE143782 calcitriol 6 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE183141 trichloroethylene macrophage 5 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE186709 GSE186711 MLL inhibition 4 v 6 human dn Gene Set (Entity type)	A Gene Set from LINCS

EGOT associations

Associations for EGOT_associations

EGOT associations.tsv

A file from IDG as part of the Harmonizome project

EGOT

ENSG00000235947 - eosinophil granule ontogeny transcript

GSE143782 calcitriol 7 v 11 human dn

A Gene Set from LINCS

GSE171692 FXN knockdown 1 v 0 human up

A Gene Set from LINCS

GSE143782 calcitriol 3 v 11 human dn

A Gene Set from LINCS

GSE239844 crizotinib 8 v 0 human up

A Gene Set from LINCS

GSE143782 calcitriol 6 v 5 human up

A Gene Set from LINCS

GSE183141 trichloroethylene macrophage 5 v 1 human up

A Gene Set from LINCS

GSE186709 GSE186711 MLL inhibition 4 v 6 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.